← Open Payments lookup

KELSEY BAUER: Open Payments

NPI 1114681889 · SIOUX CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$962 in 56 payments from 10 companies in 2025. Trend: 2023 $271 · 2024 $651 · 2025 $962

Food & beverage: $962
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$213
ABBVIE INC.12$165
E.R. Squibb & Sons, L.L.C.11$153
Otsuka America Pharmaceutical, Inc.6$112
Vanda Pharmaceuticals Inc.3$82
Alkermes, Inc.4$78
Supernus Pharmaceuticals, Inc.3$50
Indivior Inc.3$46
Lundbeck LLC2$41
Axsome Therapeutics, Inc.1$22

Products named: CAPLYTA, COBENFY, VRAYLAR, REXULTI, ARISTADA, FANAPT, Qelbree, SUBLOCADE.

Industry payments across IA — which companies pay providers there.